Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
PJT Partners Inc is a capital markets business based in the US. PJT Partners shares (PJT) are listed on the NYSE and all prices are listed in US Dollars. PJT Partners employs 833 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $69.98 |
|---|---|
| 52-week range | $54.31 - $88.75 |
| 50-day moving average | $71.11 |
| 200-day moving average | $71.89 |
| Wall St. target price | $83.83 |
| PE ratio | 28.4534 |
| Dividend yield | $0.4 (1.4%) |
| Earnings per share (TTM) | $2.47 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $69.98 from 2022-07-01
| 1 week (2022-06-29) | -1.84% |
|---|---|
| 1 month (2022-06-03) | -9.32% |
| 3 months (2022-04-04) | 9.31% |
| 6 months (2022-01-06) | -4.20% |
| 1 year (2021-07-06) | -2.03% |
|---|---|
| 2 years (2020-07-06) | 38.52% |
| 3 years (2019-07-05) | 71.31% |
| 5 years (2017-07-05) | 74.47% |
Valuing PJT Partners stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PJT Partners's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PJT Partners's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, PJT Partners shares trade at around 28x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
PJT Partners's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.36. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PJT Partners's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $1 billion |
|---|---|
| Operating margin TTM | 21.92% |
| Gross profit TTM | $966.8 million |
| Return on assets TTM | 19.92% |
| Return on equity TTM | 29.29% |
| Profit margin | 10.19% |
| Book value | $5.24 |
| Market capitalisation | $2.8 billion |
TTM: trailing 12 months
Dividend payout ratio: 77.85% of net profits
Recently PJT Partners has paid out, on average, around 77.85% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.4% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), PJT Partners shareholders could enjoy a 1.4% return on their shares, in the form of dividend payments. In PJT Partners's case, that would currently equate to about $0.4 per share.
PJT Partners's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
PJT Partners's most recent dividend payout was on 21 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 6 June 2022 (the "ex-dividend date").
Over the last 12 months, PJT Partners's shares have ranged in value from as little as $54.3051 up to $88.7536. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while PJT Partners's is 0.7904. This would suggest that PJT Partners's shares are less volatile than average (for this exchange).
PJT Partners Inc. , an investment bank, provides various strategic and capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments worldwide. It offers advisory services to clients on various transactions, including mergers and acquisitions (M&A), spin-offs, activism defense, contested M&A, joint ventures, minority investments, and divestitures. The company also advises private and public company boards and management teams on strategies for building productive investor relationships with a focus on shareholder engagement; and strategic investor relations; environmental, social, and governance matters; and other investor-related matters. In addition, it provides advisory services related to debt and acquisition financings; structured product offerings; public equity raises, including initial public offering and SPAC offerings; and private capital raises for early and later stage companies, as well as other capital structure related matters. Further, the company offers advisory services in restructurings and recapitalizations; and serving a range of companies, creditors, and financial sponsors on liability management and related capital raise transactions, including exchanges, recapitalizations, reorganizations, debt repurchases, and distressed mergers and acquisitions. Additionally, it provides private fund advisory and fundraising services for a range of investment strategies; and advisory services to GPs and LPs on liquidity and other structured solutions in the secondary market.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.